CoChat

Tumor Microenvironment and Angiogenesis

· 2007 · Antiangiogenic Cancer Therapy
Cited by 145

The DOI matches its Crossref record.

Abstract

References .......................................................................................................................... 142 The major clinical challenge of systemic cancer therapy is not eradication of the primary tumor, which can be treated with radiation or surgery, but eradication of metastases, which are usually present at the time of initial diagnosis and are likely to be resistant to conventional chemotherapy (1-3). A principal barrier to the destruction of disseminated cancer is the heterogeneous nature of cancer. This heterogeneity is exhibited in a wide range of biologic entities such as cell-surface receptors, enzymes, and karyotypes, and in cellular features, such as morphologic characteristics, growth properties, sensitivity to chemotherapeutic drugs, and the ability to invade and metastasize (3,4-6). Neoplastic transformation involves genetic alterations, such as the activation or dysregulation of oncogenes (7), and cells that are able to circumvent normal growth-control mechanisms may undergo continuous selection pres- sures. Unfortunately, this continuous evolution of genetically unstable neoplasms eventually favors the emergence of subpopulations of cells with metastatic potential.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1201/9781420004298-10

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

Metadata

Venue
Antiangiogenic Cancer Therapy
Publisher
CRC Press
Published
2007-07-25
Pages
149-166
OpenAlex
W4247712778
Cited by
145
References
0
FWCI
17.03
Type
book chapter
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.